S&P 500   5,067.00 (-0.22%)
DOW   38,853.28 (-0.31%)
QQQ   435.95 (-0.38%)
AAPL   180.79 (-1.01%)
MSFT   407.51 (+0.01%)
META   486.87 (-0.04%)
GOOGL   135.98 (-2.09%)
AMZN   173.86 (+0.18%)
TSLA   203.68 (+1.98%)
NVDA   783.71 (-0.42%)
NIO   5.49 (-5.02%)
AMD   176.06 (-1.09%)
BABA   75.10 (-3.32%)
T   17.02 (+1.13%)
F   12.37 (+3.08%)
MU   89.71 (-2.33%)
CGC   3.41 (-3.40%)
GE   155.13 (+0.74%)
DIS   110.70 (+1.17%)
AMC   4.87 (+1.25%)
PFE   27.16 (+1.00%)
PYPL   60.52 (+0.60%)
XOM   104.18 (+0.14%)
S&P 500   5,067.00 (-0.22%)
DOW   38,853.28 (-0.31%)
QQQ   435.95 (-0.38%)
AAPL   180.79 (-1.01%)
MSFT   407.51 (+0.01%)
META   486.87 (-0.04%)
GOOGL   135.98 (-2.09%)
AMZN   173.86 (+0.18%)
TSLA   203.68 (+1.98%)
NVDA   783.71 (-0.42%)
NIO   5.49 (-5.02%)
AMD   176.06 (-1.09%)
BABA   75.10 (-3.32%)
T   17.02 (+1.13%)
F   12.37 (+3.08%)
MU   89.71 (-2.33%)
CGC   3.41 (-3.40%)
GE   155.13 (+0.74%)
DIS   110.70 (+1.17%)
AMC   4.87 (+1.25%)
PFE   27.16 (+1.00%)
PYPL   60.52 (+0.60%)
XOM   104.18 (+0.14%)
S&P 500   5,067.00 (-0.22%)
DOW   38,853.28 (-0.31%)
QQQ   435.95 (-0.38%)
AAPL   180.79 (-1.01%)
MSFT   407.51 (+0.01%)
META   486.87 (-0.04%)
GOOGL   135.98 (-2.09%)
AMZN   173.86 (+0.18%)
TSLA   203.68 (+1.98%)
NVDA   783.71 (-0.42%)
NIO   5.49 (-5.02%)
AMD   176.06 (-1.09%)
BABA   75.10 (-3.32%)
T   17.02 (+1.13%)
F   12.37 (+3.08%)
MU   89.71 (-2.33%)
CGC   3.41 (-3.40%)
GE   155.13 (+0.74%)
DIS   110.70 (+1.17%)
AMC   4.87 (+1.25%)
PFE   27.16 (+1.00%)
PYPL   60.52 (+0.60%)
XOM   104.18 (+0.14%)
S&P 500   5,067.00 (-0.22%)
DOW   38,853.28 (-0.31%)
QQQ   435.95 (-0.38%)
AAPL   180.79 (-1.01%)
MSFT   407.51 (+0.01%)
META   486.87 (-0.04%)
GOOGL   135.98 (-2.09%)
AMZN   173.86 (+0.18%)
TSLA   203.68 (+1.98%)
NVDA   783.71 (-0.42%)
NIO   5.49 (-5.02%)
AMD   176.06 (-1.09%)
BABA   75.10 (-3.32%)
T   17.02 (+1.13%)
F   12.37 (+3.08%)
MU   89.71 (-2.33%)
CGC   3.41 (-3.40%)
GE   155.13 (+0.74%)
DIS   110.70 (+1.17%)
AMC   4.87 (+1.25%)
PFE   27.16 (+1.00%)
PYPL   60.52 (+0.60%)
XOM   104.18 (+0.14%)

Medtronic (MDT) Stock Forecast & Price Target

$83.53
-0.31 (-0.37%)
(As of 01:58 PM ET)

Medtronic Consensus Analyst Rating and Stock Price Forecast (2024)

MarketBeat calculates consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0 to .5 = Strong Sell, .5 to 1 = Sell, 1 to 1.5 = Reduce, 1.5 to 2.5 = Hold, 2.5 to 3.0 = Moderate Buy, 3.0 to 3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.

Analysts' Consensus Rating

Hold
Based on 11 Analyst Ratings

Analysts' Consensus Price Target

$94.91
13.62% Upside
High Forecast$106.00
Average Forecast$94.91
Low Forecast$82.00
TypeCurrent Forecast
2/28/23 to 2/28/24
1 Month Ago
1/29/23 to 1/29/24
3 Months Ago
11/30/22 to 11/30/23
1 Year Ago
2/28/22 to 2/28/23
Consensus Rating
Hold
Hold
Hold
Hold
Strong Buy
0 Strong Buy rating(s)
0 Strong Buy rating(s)
0 Strong Buy rating(s)
0 Strong Buy rating(s)
Buy
6 Buy rating(s)
6 Buy rating(s)
6 Buy rating(s)
4 Buy rating(s)
Hold
4 Hold rating(s)
4 Hold rating(s)
4 Hold rating(s)
14 Hold rating(s)
Sell
1 Sell rating(s)
1 Sell rating(s)
1 Sell rating(s)
1 Sell rating(s)
Consensus Price Target$94.91$93.92$93.33$90.72
Predicted Upside13.62% Upside11.68% Upside12.04% Upside7.08% Upside
Get Medtronic Upgrade and Downgrade Alerts

Sign-up to receive the latest news and ratings for MDT and its competitors with MarketBeat's FREE daily newsletter.


MDT Analyst Ratings By Month

The chart below shows how a company's ratings by analysts have changed over time. Each bar represents the previous year of ratings for that month. Within each bar, the sell ratings are shown in red, the hold ratings are shown in yellow, the buy ratings are shown in green, and the strong buy ratings are shown in dark green.
Skip Chart & View Analyst Rating History

MDT Price Targets by Month

The chart below shows how a company's share price and consensus price target have changed over time. The dark blue line represents the company's actual price. The lighter blue line represents the stock's consensus price target. The even lighter blue range in the background of the two lines represents the low price target and the high price target for each stock.
Skip Chart and View Analyst Price Target HistorySkip Chart & View Price History Table

Medtronic Stock vs. The Competition

TypeMedtronicMedical CompaniesS&P 500
Consensus Rating Score
2.45
2.68
2.48
Consensus RatingHoldModerate BuyHold
Predicted Upside13.79% Upside1,735.25% Upside7.79% Upside
News Sentiment RatingPositive News
Positive News
Positive News

Recent Analyst Ratings and Stock Forecasts

DateBrokerageAnalyst NameActionRatingPrice TargetUpside/Downside on Report DateDetails
2/21/2024Royal Bank of Canada
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Reiterated RatingSector Perform ➝ Sector Perform$92.00+7.60%
2/21/2024Mizuho
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost TargetBuy ➝ Buy$95.00 ➝ $98.00+14.71%
2/21/2024Oppenheimer
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost TargetMarket Perform ➝ Market Perform$89.00 ➝ $92.00+7.69%
2/21/2024Truist Financial
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost TargetHold ➝ Hold$87.00 ➝ $90.00+4.83%
11/22/2023Morgan Stanley
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Lower TargetOverweight ➝ Overweight$104.00 ➝ $98.00+24.68%
8/23/2023UBS Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost TargetSell ➝ Sell$79.00 ➝ $82.00-2.05%
8/23/2023Wells Fargo & Company
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost TargetOverweight ➝ Overweight$100.00 ➝ $102.00+21.83%
8/22/2023Stifel Nicolaus
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost TargetBuy ➝ Buy$92.00 ➝ $95.00+13.47%
7/18/2023Robert W. Baird
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Initiated CoverageNeutral$90.00+3.91%
6/30/202322nd Century Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Reiterated RatingInitiates
6/30/2023CL King
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Initiated CoverageBuy$106.00+22.16%
5/26/2023Sanford C. Bernstein
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Lower Target$100.00 ➝ $99.00+18.51%
4/24/2023Barclays
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 UpgradeEqual Weight ➝ Overweight

Analyst ratings data on MarketBeat is provided by Benzinga and other data providers. This page was last refreshed on Wednesday at 11:00 AM ET.












MDT Price Target - Frequently Asked Questions

What is Medtronic's consensus rating and price target?

According to the issued ratings of 11 analysts in the last year, the consensus rating for Medtronic stock is Hold based on the current 1 sell rating, 4 hold ratings and 6 buy ratings for MDT. The average twelve-month price prediction for Medtronic is $94.91 with a high price target of $106.00 and a low price target of $82.00. Learn more on MDT's analyst rating history.

Do Wall Street analysts like Medtronic more than its competitors?

Analysts like Medtronic less than other Medical companies. The consensus rating for Medtronic is Hold while the average consensus rating for medical companies is Moderate Buy. Learn more on how MDT compares to other companies.

Does Medtronic's stock price have much upside?

According to analysts, Medtronic's stock has a predicted upside of 12.33% based on their 12-month stock forecasts.

What analysts cover Medtronic?

Medtronic has been rated by Mizuho, Oppenheimer, Royal Bank of Canada, and Truist Financial in the past 90 days.


Stock Ratings Reports and Tools

This page (NYSE:MDT) was last updated on 2/28/2024 by MarketBeat.com Staff